Elisalex Medipro SRL

Elisalex Medipro reported total assets of €1.33m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Dec 2025).

Company number (CBE) 0897.492.795 · VAT BE0897492795
1081 Koekelberg
active in Medical specialists activities (NACE 86220)
operating since 14 Apr 2008 (≈ 18 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Elisalex Medipro shows with a free account.

See the score
Profile
SRL since 2008
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result168,594 €
Equity€1.30m
Cash92,969 €
EBITDA205,497 €
Total assets€1.33m
The line marks its sector median: 67.4% (1646 companies).

Change 2022 → 2025: Equity +13 % Total assets +13 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Elisalex Medipro's annual accounts

20252024202320222021
Net result168,594 €
Equity€1.30m
Cash92,969 €
EBITDA205,497 €
Total assets€1.33m

Filed annual accounts

  • Year ended 30 Jun 2025filed on 19 Dec 2025
  • Year ended 30 Jun 2024filed on 16 Dec 2024
  • Year ended 30 Jun 2023filed on 18 Dec 2023
  • Year ended 30 Jun 2022filed on 22 Dec 2022
  • Year ended 30 Jun 2021filed on 05 Jan 2022

Elisalex Medipro's financial analysis

Management and control of Elisalex Medipro

1 active director(s) in the register.

Elisalex Medipro's shareholders and holdings →

Elisalex Medipro's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0897.492.795
VAT number
BE0897492795
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
14 Apr 2008
Registered office
1081 Koekelberg
Latest accounts
2025 · filed on 19 Dec 2025
Activity
Medical specialists activities (NACE 86220)

Elisalex Medipro (SRL) has been based in Koekelberg since 2008, active in: medical specialists activities. For 2025, it reports a net profit of 168,594 € and equity of €1.30m; its revenue is not published. Its solvency stands at 98.3%, above the median of its sector (67.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Elisalex Medipro

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Elisalex Medipro

What is the revenue of Elisalex Medipro?

Elisalex Medipro files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Elisalex Medipro?

In Belgium, the VAT number is the company number prefixed with BE: BE0897492795 for Elisalex Medipro, if the company is VAT-registered. Its company number (CBE) is 0897.492.795.

Where is the registered office of Elisalex Medipro?

According to the CBE register, the registered office of Elisalex Medipro is in 1081 Koekelberg.

What is the equity of Elisalex Medipro?

At the close of the 2025 financial year, the equity of Elisalex Medipro amounts to 1,302,844 €, a solvency of 98.3% of total assets.

Who manages Elisalex Medipro?

The register lists 1 active mandates at Elisalex Medipro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Elisalex Medipro

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Sep 2026

No credit card, no commitment.

What each plan unlocks →